Home Control（1747.HK）变更非执行董事团队，市场展望强化企业管治，灵活拓展家居医疗业务

Core Viewpoint - Home Control (1747.HK) has undergone a board restructuring, reducing the number of directors from 9 to 6, which is expected to enhance the board's responsiveness and effectiveness in supporting the company's expansion into home healthcare and improving governance [1][2]. Group 1: Board Changes - The recent board changes include the resignation of non-executive director and chairman Alain Perrot, along with three independent non-executive directors, indicating a strategic shift as the company advances its AIoT-enabled home healthcare ecosystem [2]. - The new independent non-executive director, Bernard Eng Chuan LIM, brings extensive financial and healthcare asset experience, aligning with Hong Kong regulations requiring at least three independent non-executive directors [2][4]. Group 2: New Board Members' Background - Bernard Eng Chuan LIM has over 30 years of multinational corporate experience and has held senior financial leadership positions, including CFO at OUE Limited for ten years, contributing to significant corporate actions and strategic investments [3]. - The newly appointed independent non-executive directors, Ye Min and Chen Yizhong, also possess rich experience in healthcare, risk management, and corporate governance, further strengthening the board's expertise in the new business direction [4]. Group 3: Company Operations - Home Control's headquarters and main operational team are based in Singapore, with a stable core management team, ensuring effective communication with the new board members who have backgrounds in Singapore or international institutions [4].